Title:miR-7 Reduces High Glucose Induced-damage Via HoxB3 and PI3K/AKT/mTOR Signaling Pathways in Retinal Pigment Epithelial Cells
VOLUME: 20 ISSUE: 5
Author(s):Zhongyi Yang, Hanying Hu, Yuling Zou, Wenbluo Luo, Lin Xie and Zhipeng You*
Affiliation:Department of Ophthalmology, The Second Affiliated Hospital of Nanchang University, Nanchang, Department of Ophthalmology, The Second Affiliated Hospital of Nanchang University, Nanchang, Department of Ophthalmology, The Second Affiliated Hospital of Nanchang University, Nanchang, Department of Ophthalmology, The Second Affiliated Hospital of Nanchang University, Nanchang, Department of Ophthalmology, The Second Affiliated Hospital of Nanchang University, Nanchang, Department of Ophthalmology, The Second Affiliated Hospital of Nanchang University, Nanchang
Keywords:miR-7, HoxB3, DR, PI3K/AKT/mTOR signaling, retinopathy, celll proliferation.
Abstract:Background: Diabetic retinopathy (DR) is a common complication of
diabetes. This study investigated the effect of miR-7 in the regulation of cell proliferation
via the HoxB3 gene and PI3K/AKT/mTOR signaling pathways in DR.
Methods: Human retinal pigment epithelial cell line (ARPE-19) cultured in normal
medium (Control) and high glucose medium (25mM glucose, HG) was transfected with
mimics NC (HG+ mimics NC), miR-7 mimics (HG+miR-7 mimics), inhibitor NC (HG+
inhibitor NC), and miR-inhibitor (HG+miR-7 inhibitor). The cells were assayed for
viability, apoptosis, and expression of genes.
Results: HG reduced cell viability and increased apoptosis. However, miR-7 mimics
reduced the apoptosis. PCR results showed that miR-7 was significantly upregulated
after transfection with miR-7 mimics. The expression of Hoxb3, mTOR, p-PI3K, and p-
AKT was significantly downregulated at mRNA and protein levels after miR-7 mimics
transfection, while no difference was observed for PI3K and AKT expression.
Conclusion: Our findings demonstrate that miR-7 regulates the growth of retinal
epithelial cells through various pathways and is a potential therapeutic target for the
prevention and treatment of diabetic retinopathy.